Breast cancer survival in England, Norway and Sweden: A population-based comparison

International Journal of Cancer

Volumn 127, Issue 11, 2010, Pages 2630-2638

  Møller, Henrik ^a   Sandin, Fredrik ^b   Bray, Freddie ^c   Klint, Åsa ^d   Linklater, Karen M ^a   Purushotham, Arnie ^e   Robinson, David ^a   Holmberg, Lars ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Cancer Registry of Norway ^*  (Norway)

^d NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

breast cancer; England; Norway; survival; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; NORWAY; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; SWEDEN; SYMPTOMATOLOGY; UNITED KINGDOM; ADOLESCENT; BREAST TUMOR; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; NEWBORN; POISSON DISTRIBUTION; PRESCHOOL CHILD; REGISTER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NORWAY; POISSON DISTRIBUTION; REGISTRIES; SURVIVAL RATE; SWEDEN; YOUNG ADULT;

EID: 78049487870     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25264     Document Type: Article

References (35)

1. Quinn MJ, Martinez-Garcia C, Berrino F,. Variations in survival from breast cancer in Europe by age and country, 1978-1989. Eur J Cancer 1998; 34: 2204-11.
2. Sant M, Capocaccia R, Verdecchia A, Estève J, Gatta G, Micheli A, Coleman MP, Berrino F,. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer 1998; 77: 679-83.
3. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, et al.; EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003; 14 (Suppl 5): 61-118.
4. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F,; EUROCARE Working Group. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106: 416-22.
5. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R,; EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
6. Improving outcomes in breast cancer. A study for the All-Party Parliamentary Group on Breast Cancer. London: House of Commons, 1998.
7. Møller H, Linklater KM, Robinson D,. A visual summary of the EUROCARE-4 results: a UK perspective. Br J Cancer 2009; 101: S110-4.
8. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, et al. European health systems and cancer care. Ann Oncol 2003; 14 (Suppl 5): 41-60.
9. Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, Iddenden R, Møller H, Sankila R, Thomson CS, Storm HH,. Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007; 121: 1115-22.
10. United Kingdom Association of Cancer Registries, Accessed April 18, 2009.
11. Westlake S,. Cancer incidence and mortality in the United Kingdom and constituent countries, 2003-05. Health Stat Q 2008; 40: 91-7.
12. National Cancer Intelligence Network, Accessed April 18, 2009.
13. Larsen IK, Smàstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B,. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218-31.
14. Barlow L, Westergren K, Holmberg L, Talbäck M,. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27-33.
15. Mattsson B, Wallgren A,. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305-13.
16. Parkin DM, Bray F,. Evaluation of data quality in the cancer registry: principles and methods. II. Completeness. Eur J Cancer 2009; 45: 756-64.
17. Ederer F, Axtell LM, Cutler SJ,. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-21.
18. Government Actuary's Department, Accessed April 18, 2009.
19. The Human Mortality Database, Accessed April 18, 2009.
20. Brenner H, Gefeller O,. An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004-10.
21. Dickman PW, Sloggett A, Hills M, Hakulinen T,. Regression models for relative survival. Stat Med 2004; 23: 51-64.
22. StataCorp. Stata Statistical Software: Release 9. College Station: StataCorp, 2005.
23. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2007; ISBN 3-900051-07-0, Available at:, Accessed March 10, 2010.
24. Waller M, Moss S, Watson J, Møller H,. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007; 16: 2257-61.
25. Vainio H, Bianchini F, eds. Breast cancer screening. IARC handbooks of cancer prevention, vol. 7. Lyon: IARC Press, 2002. 49-50.
26. Ferlay J, Bray F, Pisani P, Parkin DM,. Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004.
27. Peto R, Boreham J, Clarke M, Davies C, Beral V,. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 20: 1822.
28. Doll R, Boreham J,. Recent trends in cancer mortality in the UK. Br J Cancer 2005; 92: 1329-35.
29. Bullard J, Coleman MP, Robinson D, Lutz JM, Bell J, Peto J,. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000; 82: 1111-6.
30. Robinson D, Sankila R, Hakulinen T, Møller H,. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 2007; 43: 909-13.
31. Wishart GC, Greenberg DC, Chou P, Brown CH, Duffy S, Purushotham AD,. Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol 2010; 21: 291-6.
32. Woods LM, Rachet B, O'Connell D, Lawrence G, Tracey E, Willmore A, Coleman MP,. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009; 15: 2391-9.
33. Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M,. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ≥65 years. Br J Cancer 2007; 96: 1197-203.
34. Lavelle K, Moran A, Howell A, Bundred N, Campbell M, Todd C,. Older women with operable breast cancer are less likely to have surgery. Br J Surg 2007; 94: 1209-15.
35. Eaker S, Dickman PW, Bergkvist L, Holmberg L,; The Uppsala/Örebro Breast Cancer Group. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PloS Med 2006; 3: 321-328.